Bemarituzumab Antibody
Bemarituzumab is a humanized monoclonal IgG1 antibody designed to inhibit FGFR2b signaling by blocking FGF ligand binding. Its application in cancer research includes targeting FGFR2b-overexpressing tumors, such as gastric and breast cancers, in both in vitro cell-based assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
FGFR, FPA144, FPA-144, FPA 144, Bemarituzumab
Target
FGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
3.55 mg/mL
Purity
100.00% (May vary between batches)
Molecular Weight
144 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-I192700-5MG 5 mg
O-(Alpha−L-Idopyranosyluronic Acid 2-Sulfate-(1-4)-2,5-anhydromannose-6-sulfate Trisodium Salt, 90%
Sign In for Pricing
View Details 
BNC742207-500 1x 500 µL
HSP60 (Heat Shock Protein 60) (Mitochondrial Marker) (rGROEL/780), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 